(Q46322333)

English

Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

toll-like receptor

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

author name string

Dongsheng Zhai

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Jinxiang Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Qichang Zheng

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Zhengliang Li

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Jinhui Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Yuan Tian

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

publication date

10 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Journal of Huazhong University of Science and Technology. Medical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

28

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

564-567

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

https://scigraph.springernature.com/pub.10.1007/s11596-008-0516-8

0 references

Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0516-8

21 January 2018

Toll-like receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic ischemia/reperfusion injury--a fresh look

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18846339

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11596-008-0516-8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18846339

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46322333&oldid=2105319670"